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a b s t r a c t
Introduction: Systemic sclerosis (SSc) is a multisystem disease, autoimmune disorder char-
acterized by a fibroblastic disfunction, with significant impact on quality of life (QoL), mea-
sured by instruments or questionnaires that usually were formulated in other languages 
and in different cultural contexts.
Objective: Translate into Brazilian Portuguese, cross cultural adaptation and assess the reli-
ability and validity of the Systemic Sclerosis Questionnaire (SySQ). 
Methodology: Translation and adaptation: into Portuguese and cross-cultural adaptation 
was performed in accordance with studies on questionnaire translation methodology into 
other languages. Reliability: it was analyzed using three interviews with different inter-
viewers, two on the same day (interobserver) and the third within 14 days of the first as-
sessment (intraobserver).Validity was assessed by correlating clinical and quality of life 
parameters with the domain scores of Sysc. Statistical analysis: a descriptive analysis of 
the study sample. Reproducibility was assessed using an intraclass correlation coefficient 
(ICC). Internal consistency was assessed using Cronbach’s alpha coefficient. To assess va-
lidity we used Spearman correlation coefficient. Five percent was the level of significance 
adopted for all statistical tests. 
Results: In the evaluation of the questionnaires, the results were similar to the original 
questionnaire, the internal consistency ranging between 0.73 and 0.93 for each item. The 
interobserver reproducibility was very good for all domains (α = 0.786 to 0.983) and intrao-
bserver agreement was considered very good for general symptoms domain (ICC = 0.916), 
good for musculoskeletal symptoms domain (ICC = 0.897) and cardiopulmonary domain 
(ICC = 0.842) and reasonable for gastrointestinal symptoms domain (ICC = 0.686). 
Conclusion: The Brazilian Portuguese version of SySQ proved to be reproducible and valid for 
our population, using a recognized methodology for translation and cultural adaptation of 
questionnaires, as well as to assess the reproducibility and validity.
© 2014 Elsevier Editora Ltda. All rights reserved.
* Corresponding author.
E-mail: eutilia@terra.com.br (E.A.M. Freire).
0482-5004/$ - see front matter. © 2014 Elsevier Editora Ltda. All rights reserved.
http://dx.doi.org/10.1016/j.rbre.2014.03.003
2255 21
96 R E V  B R A S  R E U M A T O L .  2 0 1 4 ; 5 4 ( 2 ) : 9 5 – 1 0 1
Tradução, adaptação cultural e validação para a língua portuguesa 
(Brasil) do Systemic Sclerosis Questionnaire (SySQ)
Palavras-chave:
Esclerose sistêmica
Qualidade de vida
Validação de questionário
r e s u m o
Introdução: A esclerose sistêmica (ES) é uma doença multissistêmica, autoimune, caracte-
rizada por disfunção fibroblástica e vasculopatia, causando grande impacto na qualidade 
de vida (QV). Esta é mensurada por instrumentos ou questionários, geralmente formulados 
em outros idiomas e inseridos em contextos culturais distintos. 
Objetivo: Traduzir, adaptar culturalmente e validar para a língua portuguesa (Brasil) o ques-
tionário do Systemic Sclerosis Questionnaire (SySQ) de QV em ES. 
Metodologia: Tradução e adaptação: etapa realizada de acordo com metodologia específi-
ca de tradução de questionários. Confiabilidade: foi analisada através de três entrevistas, 
realizadas por diferentes entrevistadores, sendo duas no mesmo dia (interobservação) e 
uma terceira após 14 dias (intraobservação). Validade: avaliada pela correlação clínica e 
parâmetros de QV com os domínios do Sysc. Análise estatística: realizada análise descri-
tiva da amostra. A reprodutibilidade foi avaliada através de um coeficiente de correlação 
intraclasse (ICC) e a consistência interna pelo coeficiente alfa de Cronbach, já para analisar 
a validade utilizou o coeficiente de correlação de Spearman. 
Resultados: Foram observados 16 pacientes portadores de ES. Os nossos resultados foram 
semelhantes aos do questionário original, com a consistência interna variando entre 0,73 
e 0,93 para cada item. A reprodutibilidade interobservador foi muito boa para todos os do-
mínios (α = 0,786 a 0,983), e a intraobservador foi muito boa para o domínio de sintomas 
gerais (CCI = 0,916), boa para os domínios de sintomas musculoesqueléticos (CCI = 0,897) e 
cardiopulmonares (CCI = 0,842) e razoáveis para o de sintomas gastrintestinais (CCI = 0,686). 
Conclusão: A versão na língua portuguesa do SySQ mostrou-se reprodutível e válida para 
nossa população através de metodologia reconhecida para tradução e adaptação cultural 
de questionários.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Systemic sclerosis (SSc) is a multisystemic autoimmune dis-
ease characterized by fibroblast dysfunction, along with mi-
crovascular involvement, culminating in skin and internal or-
gans fibrosis.1 Clinically, the extent of cutaneous and internal 
organ involvement by this disease and its severity vary a great 
deal.2 The disease usually follows a chronic, monophasic and 
indolent course, and only in rare cases relapses occur.
The course of the disease is slow and indolent without 
major complications that interfere significantly with the 
quality of life of the affected individual. Nevertheless SSc can 
exhibit progressive cutaneous and vascular involvement, re-
sulting in considerable morbidity with impaired physical 
and functional appearance, which can lead to a decreased 
social adequacy. Severe gastrointestinal, renal, and cardiac 
affections, hypertension and/or interstitial lung disease con-
tribute to the mortality rate of the disease, as well as to in-
dividual and social performance. Compared with systemic 
sclerosis, few clinical conditions cause such functional and 
organic limitations; these issues should be addressed spe-
cifically during the evaluation of these patients.
In the last two decades, the results of the assessment 
focused on the patient's opinion demonstrate a significant 
role in the study of chronic diseases, in addition to the mor-
bidity and mortality traditionally measured. In the Ameri-
can College of Rheumatology (ACR), the outcome measures 
in clinical trials committee, OMERACT (Outcome Measures 
in Rheumatology Clinical Trials)3 has recognized the impor-
tance of the measurement of function and welfare from the 
perspective of the patient,as a criteria to determine clinical 
improvement.
Physiological measures provide essential information to 
clinicians, but often correlate less with functional capacity 
and welfare; aspects which patients are familiar and most 
interested in.
These assessment measures, increasingly used in clinical 
trials, are instruments or questionnaires that, for the most 
part, were formulated in English, targeted for it’s use in the 
English-speaking population and can be generic or specific 
for certain conditions. In order for them to be used in other 
populations, measures should follow pre-established norms 
published in the literature for its translation in a specific cul-
tural context.4 And for the clinical use in a specific popula-
tion, their psychometric properties also must to be validated 
locally, in order to make sure that they are reliable for the as-
sessment of what they propose. The properties of a measure 
are its reliability, validity and responsiveness.5
Ruof et al.6 developed a questionnaire often reported by 
patients with this disease covering the functional impact 
of systemic sclerosis as well as general and visceral symp-
toms: the Systemic Sclerosis Questionnaire (SySQ) (Fig. 1). 
The questionnaire was developed in German, containing 32 
questions divided into 4 categories (general, gastrointesti-
nal, musculoskeletal and cardiopulmonary symptoms).
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The Likert scale (graded 1-4) was used to score the items 
due to its ease of understanding, referring to the ability 
to perform an activity (1 means “without difficulty” and 4 
means “unable”), intensity of symptoms (0 corresponds to 
“absent” and 4 to “very intense”) and frequency of symp-
toms (1 equals to “never” and 4 to “always”). Without a doubt, 
the Likert scale is a valid and reproducible measure in this 
population. 
In Brazil, we have no specific questionnaires to assess 
SSc patients validated for use in our population. The aim of 
this study was to translate into Brazilian Portuguese, adapt 
cultural differences and validate the SySQ questionnaire, so 
that it can be used in clinical practice and in clinical trials 
involving SSc patients in Brazil.
Methodology
For our sample composition, 16 SSc patients seen at the Rheu-
matology Service of the Federal University of Paraíba, from 
various locations in the State of Paraíba, were randomly se-
lected, fulfilling the inclusion criteria of the study: age be-
tween 18 and 65 years, diagnosis of systemic sclerosis accord-
ing to the criteria of the American College of Rheumatology 
(ACR), and absence of dementia or cognitive impairment.
Participants were characterized based on a protocol contain-
ing sociodemographic and clinical data. They were assessed by 
the Health Assessment Questionnaire with the visual analogue 
scale (VAS) for functional status, for systemic sclerosis (sHAQ) 
and for quality of life by the Medical Outcomes Study 36-Item 
Short Form Health Survey (SF-36). The questionnaires were ap-
plied to patients by interviewers, given the socio-cultural level 
QUESTIONNAIRE OF QUALITY OF LIFE IN SYSTEMIC 
SCLEROSIS 
Thank you for completing this questionnaire. It will let 
us know more about day-to-day problems that affect 
patients with systemic sclerosis. It will also help us to 
better understand and maybe permit us to improve the 
treatment of this disease. For each item, mark only one 
number that best demonstrates the effect/importance 
in your life. Please do not ask for help to answer these 
questions, because you are the best person to know about 
your illness and how it affects you. There are no right or 
wrong answers.
Please use this scale to answer the following questions:
1  without difficulty; 
2  with little difficulty; 
3  with great difficulty; 
4  impossible.
Can you ... 
01. Cutting meat with a knife? 1  2  3  4  
02. Bathing and drying yourself alone? 1  2  3  4  
03. Putting on socks? 1  2  3  4  
04. Rubbing cream on your body? 1  2  3  4 
05. Opening and closing a tap? 1  2  3  4  
06. Getting up from a chair that does not have armrests? 1  2  
3  4  
07. Lie down and get up from bed? 1  2  3  4  
08. Walking on a flat street? 1  2  3  4  
09. Climbing stairs? 1  2  3  4  
10. Eating large pieces of food without cutting them? 1  2  3  
4  
11. Eating an apple? 1  2  3  4 
Please use this scale to answer the following questions:
1 no;
2 light;
3 moderate;
4 strong.
Do you feel...
01. Pain in fingers when touching or holding objects? 1  2  3  
4  
02. Stiffness in your hands? 1  2  3  4  
03. Stiffness in the arms? 1  2  3  4  
04. Stiffness in the legs? 1  2  3  4  
05. Pain in your hands when it's cold? 1  2  3  4  
06. Pain in your feet when it gets cold? 1  2  3  4  
07. Shortness of breath when walking on a flat street? 1  2  3  4  
08. Shortness of breath when climbing a ladder (2 stairs with about 
10 steps) 1  2  3  4  
09. Shortness of breath when changing clothes? 1  2  3  4 
Do you have ... 
10. Cough? 1  2  3  4  
11. Chest catarrh? 1  2  3  4  
12. Difficulty with deep breathing? 1  2  3  4 
Please use this scale to answer the following questions:
1  No; 
2  Occasionally; 
3  Several times; 
4  Always.
Please use this scale to answer the following questions:
1  No; 
2  Occasionally; 
3  Several times; 
4  Always.
Do you... 
01. Feel weak hands when holding objects? 1  2  3  4  
02. Drop objects you are holding from your hand? 1  2  3  4  
03. Feel pain in your hands? 1  2  3  4  
04. Have cold hands? 1  2  3  4  
05. Have difficulty to swallowing? 1  2  3  4  
06. Feel pain when swallowing food? 1  2  3  4  
07. Choke during meals? 1  2  3  4  
08. Have heartburn? 1  2  3  4  
09. Feel that the food is returning after swallowing it? 1  2  3  4 
PUNCTUATION Score Min – Max
General symptoms (G1 a G8) 0 - 24
Gastrointestinal symptoms 
(GI 1 A G17)
0-21
Musculoskeletal symptoms 
(ME1 a ME11)
0-33
Cardiopulmonary symptoms 
(CP1 a CP6)
0-18
Fig. 1 – Questionnaire of quality of life in systemic sclerosis 
translated and adapted into brazilian portuguese.
98 R E V  B R A S  R E U M A T O L .  2 0 1 4 ; 5 4 ( 2 ) : 9 5 – 1 0 1
of the population studied. Data were cataloged in an Excel 2010 
worksheet and analyzed using SPSS version 20.
Translation and cultural adaptation
The translation and cultural adaptation followed the meth-
odology used by other studies, according to Falcão et al.7 The 
instrument was first translated into Portuguese by a transla-
tor fluent in German (creating the first version in Portuguese). 
The initial translation was reverted to the original language 
(back translation), and was then compared to the original in-
strument. The discrepancies found were reviewed by a rheu-
matologist and a general practitioner, together with transla-
tors who participated in the previous steps, adapting them to 
generate a second version in Portuguese.
At this step, the semantic equivalence was analyzed based 
on vocabulary and grammar correspondence, idiomatic 
equivalence, translation of idiomatic expressions and also 
conceptual equivalence, since the terms could have semantic 
equivalence without conceptual equivalence.
Then, this version was applied to a group of five patients, 
being added to each of the questions the "not applicable" op-
tion, in order to identify questions that were not understood 
or that are not regularly used by our population, and thus 
considered culturally inappropriate.
The questions with more than 25% of responses "not ap-
plicable" were analyzed by the committee, and then replaced 
by others with the same concept. These changes led to new 
versions of the questionnaire, which were reapplied to these 
patients until no item was considered "not applicable" by 
more than 15% of patients, generating the final Brazilian Por-
tuguese version of the questionnaire.
Assessment of psychometric measures of the questionnaire
The reliability of the final version of the translated question-
naire was evaluated through three interviews with each pa-
tient, two held on the same day by two different interviewers 
(interviewer 1 and 2) to evaluate the interobserver reproduc-
ibility, and the third interview was done 14 days after the first 
assessment by the interviewer 1, to address intraobserver re-
producibility. In the first case, we used the intraclass corre-
lation coefficient (ICC); for internal analysis of the questions 
consistency, Cronbach's alpha was calculated.
Validation
The validity of the questionnaire was assessed by checking the 
ratio of its scores by domain area with preexisting question-
naires of functional assessment (HAQ and sHAQ) and of quality 
of life (SF-36). The Spearman correlation coefficient was used.
Results
Sixteen SSc patients, 13 females (13/16) and 3 males (3/16), 
were analyzed. The mean age was 45.5 years, and the sociode-
mographic and clinical characterization is described in Table 1.
The questionnaire was translated according to the above 
methodology. In the pre-test, two questions were consid-
ered as “not applicable” by patients. The question “Você 
consegue levantar-se de uma cadeira sem a ajuda dos braços?” 
(“Can you get up from a chair without help of your arms?”) 
was not understood by four of the five patients who report-
ed not understand the meaning of “arm”, if it was their own 
arm or the arm of the chair. After consideration of the com-
mittee, the question was changed to “Você consegue levantar-
se de uma cadeira que não tenha apoio para os braços?” (“Can 
you get up from a chair that does not have armrests?”).
Another question not understood was “Você tem regur-
gitação?” (“Do you have regurgitations?”). Again, when four 
out of five patients did not understand it, an additional ex-
planation was needed: “O alimento volta após as refeições?” 
(“Does the food pours back after meals?”). This question 
was modified by the committee to “Sente que o alimento volta 
após engolir?” (“Do you feel that the food returns after swal-
lowing it?”). These changes have generated a new version 
of the questionnaire, which was reapplied to the group of 
five patients until no item was considered “not applicable” 
by more than 15% of patients after the questions were re-
formulated. 
The scores obtained by patients in each SySQ domain 
are presented in Table 2. 
Table 1 – Socioeconomic and clinical characteristics of 16 
patients with systemic sclerosis.
Gender 
Male 3
Female 13
Age (years) 
Mean 44.96
Ethnicity 
White 5
Black 3
Brown 8
Education 
Illiterate 0
Incomplete Elementary School 9
Full Elementary School 1
Incomplete High School 2
Full High School 3
Incomplete Higher Education 0
Full Higher Education 1
Form of clinical involvement 
General symptoms 16 
Gastrointestinal 6
Musculoskeletal 10
Cardiopulmonary 10
Renal 0
Subtype of systemic sclerosis 
Diffuse 12
Limited 2
Sine scleroderma 0
Overlapping 2
Systemic lupus erythematosus 1
Rheumatoid arthritis 1
Patients with Raynaud phenomenon 
Mean time (years) 15
Severity (0 - 10) 5
Mean of attacks per week 4.81
Disease duration (years) 4.93
Mean
Gender 9.33
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The internal consistency among domains and for each do-
main is shown in Table 3, using Cronbach's alpha, as well as 
the interobserver reproducibility, through the intraclass corre-
lation coefficient. 
We compared the translated questionnaire with other in-
struments already validated in the literature: the generic qual-
ity of life questionnaire SF-36, the questionnaire of functional 
assessment HAQ plus visual analog scale for symptoms of SSc, 
composing the Scleroderma HAQ (sHAQ).
The SySQ domains were compared to SF-36 domains, as 
shown in Table 4. The general symptoms domain of SySQ 
revealed a strong correlation with the social aspects do-
main of SF-36, and a moderate correlation with the pain, 
general condition and vitality domains of the latter ques-
tionnaire.
A strong correlation between the musculoskeletal symp-
toms domain and the emotional domain of SF-36 was also 
found, besides a moderate correlation with functional ca-
pacity, pain, and physical and social aspects domains of SF-
36. The cardiopulmonary symptoms domain of SySQ had 
strong correlation with the functional capacity domain of 
SF-36 and moderate correlation with the domains physical 
aspects, pain, and general condition. The gastrointestinal 
symptoms domain of SySQ had no correlation with SF-36.
Table 5 shows the level of correlation between domains 
of SySQ and HAQ, but there was no relevant statistical sig-
Table 2 – Scores obtained by domain of SySQ questionnaire of 16 patients with systemic sclerosis.
Domains Minimum Maximum Mean Standard Deviation
General symptoms (0-24) 0 21 9.8 6.9
Gastrointestinal symptoms (0-21) 0 21 7.4 4.9
Musculoskeletal symptoms (0-33) 1 24 12.2 7.2
Cardiopulmonary symptoms (0-18) 0 16 5 4.8
Table 3 – Internal consistency and reproducibility of the SySQ questionnaire in 16 patients with systemic sclerosis, using 
Cronbach’s alpha and intraclass correlation coefficient, respectively.
Domains Interobserver Intraobserver
General symptoms 0.983 0.916
Gastrointestinal symptoms 0.786 0.647
Musculoskeletal symptoms 0.959 0.897
Cardiopulmonary symptoms 0.924 0.842
Internal consistence among domains 0.765
Table 4 – Correlation among SySQ and SF-36 domains.
SySQ SF-36 General symptoms Gastrointestinal 
symptoms 
Musculoskeletal 
symptoms 
Cardiopulmonary 
symptoms 
Functional capacity -0.459 -0.190 -0.656b -0.725a
Physical aspects -0.473 -0.344 -0.633b -0.545b
Pain -0.559b 0.255 -0.662b -0.502a
General state -0.600b 0.164 -0.672b -0.511a
Vitality -0.619b 0.025 -0.352 -0.094
Social aspects -0.707b 0.203 -0.541a -0.288
Emotional aspects -0.390 0.258 -0.782b -0.160
Mental health -0.246 -0.19 -0.457 -0.090
a p < 0.05.
b p < 0.01.
Table 5 – Correlation among SySQ domains and of HAQ and sHAQ domains.
SySQ HAQ e sHAQ General symptoms Gastrointestinal 
symptoms 
Musculoskeletal 
symptoms 
Cardiopulmonary 
symptoms
Dressing up 0.150 0.184 0.061 0.162
Stand up -0.083 0.118 0.188 0.199
Eating 0.253 0.199 0.158 0.929
Walk -0.011 0.091 0.207 0.104
Personal hygiene -0.84 0.172 0.134 0.002
Reaching objects 0.152 0.079 0.134 0.203
Grasping objects 0.272 0.222 0.238 0.230
Other activities 0.019 0.156 0.179 0.231
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nificance. In the other hand, Table 6 shows the correlation 
between the  SySQ domains with the domains of visual an-
alogue scale (VAS) for SSc of sHAQ. Strong correlation was 
found between the gastrointestinal symptoms domain of 
SySQ and pulmonary involvement of sHAQ.
Discussion
Assessment measures focused on the patient’s perception 
have been increasingly used as tools to determine clinical im-
provement in clinical trials and in the clinical practice. For 
clinical use in a given population, these measures need to 
have the psychometric properties assessment validated lo-
cally in order to make sure they actually measure what they 
purport to measure.
In Brazil, we lack specific instruments in Portuguese to 
evaluate SSc patients; unlike other rheumatic diseases, spe-
cific questionnaires to evaluate patients with this condition 
are scarce in the literature. The Health Assessment Question-
naire (HAQ) Disability Index (a questionnaire that assesses 
functional capacity, developed with the cooperation of rheu-
matoid arthritis patients) is commonly used in clinical trials 
involving these patients. 
Ruof et al.6 developed a self-administered questionnaire in 
German covering specific (general, gastrointestinal and car-
diopulmonary) symptoms and functional limitations caused 
by SSc. The general symptomatology described was pain, 
stiffness and skin coolness. The musculoskeletal symptoms 
analyzed were changes in performance of complex motor 
functions, hand strength, elevation of extremities and gait. 
The cardiopulmonary symptoms evaluated were dyspnea and 
upper airway symptoms (cough, expectoration and limitation 
of inspiration); the gastrointestinal symptoms were heart-
burn, regurgitation and difficulty swallowing and feeding. 
A limitation of this questionnaire is that it does not evalu-
ate important items such as Raynaud's phenomenon and re-
nal involvement which are not covered by SySQ. Nevertheless, 
this questionnaire captures more appropriately the visceral 
symptoms of the disease, when compared to other published 
instruments.
In our study, the translated questionnaire proved to be re-
producible, which attests to its reliability, suggesting that it 
can be used to evaluate SSc patients. In Brazil, this measure 
is important, because some questions had to be modified in 
the process of cultural adaptation. Our results resemble those 
obtained from the original questionnaire, which showed in-
ternal consistency ranging from 0.73 to 0.93 for each item. De-
spite the small sample size, justified by the rarity of the dis-
ease, no major damage was caused to the statistical analysis 
used, due to the rigor of the methodology adopted.
The interobserver reproducibility was good for all domains 
(α ranging from 0.786-0.983). The intraobserver reproducibility 
was considered very good for the general symptoms domain 
(ICC = 0.916), good for the musculoskeletal symptoms (ICC = 
0.897) and cardiopulmonary (ICC = 0.842) domains, and rea-
sonably good for the gastrointestinal symptoms (ICC = 0.686) 
domain. Therefore, the questionnaire is considered to be re-
producible. Similarly, the original instrument obtained α ≥ 
0.65 for all domains.
To test the validity of the questionnaire, we compared its 
scores with those obtained by previously validated question-
naires in the literature, bearing in mind that they would not 
be the best tools to compare, since, unlike SySQ, they are not 
specific to the disease. 
Among all SySQ domains, “musculoskeletal symptoms” 
was the one that showed the highest number of clinically 
satisfactory correlations with the SF-36 domains, followed by 
general and cardiopulmonary symptoms domains, since this 
is a more comprehensive questionnaire. The gastrointestinal 
symptoms domain showed correlation only with pulmonary 
involvement domain of sHAQ.
Cruz-Dominguez et al.8 translated the questionnaire into 
Spanish with the collaboration of Mexican patients, with sim-
ilar results but with a weak correlation with disease severity 
index (p = 0.526, p <0.0001). Our service does not have the re-
quired exams for the classification of disease severity; there-
fore, this topic was excluded from the assessment of patients. 
There was no statistically significant correlation with the 
HAQ domains, a functional assessment questionnaire, which 
can be explained by the fact that SySQ may be a more com-
prehensive questionnaire regarding symptoms caused by SSc.
Khanna and Merkel9 claim that there was great progress 
in the development and validation of assessment measures 
in SSc, with these measures moving increasingly toward the 
realm of systems specifically involved with SSc.
One shortcoming of this questionnaire is that it does not 
assess Raynaud's phenomenon or renal involvement, impor-
tant manifestations of the disease, but the author suggests 
the use of a visual analogue scale for Raynaud's phenomenon 
and physical (blood pressure determination) and laboratory 
(serum urea and creatinine) exams for renal involvement.6
The version of SySQ into Brazilian Portuguese proved to be 
reproducible and valid for use in our population, using recog-
nized methodology for translation and doing the needed cul-
tural adaptation of the questionnaires, as well as to assess its 
reproducibility and validity. Studies that assess its response 
sensitivity to clinical changes over time are needed.
Table 6 – Correlation among SySQ domains and the Visual Analogue Scale for SS (sHAQ) domains.
SySQ EVA General symptoms Gastrointestinal 
symptoms
Musculoskeletal 
symptoms
Cardiopulmonary 
symptoms 
Raynaud’s phenomenon 0,133 0,351 0,058 0,400
Gastrointestinal 0,108 0,203 0,340 0,389
Lung involvement -0,215 0,724a -0,003 0,344
Pain 0,189 0,07 -0,003 0,099
Disease severity 0,407 0,024 0,281 0,380
a p < 0,01
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